Rx-360® is pleased to announce its 2024 Board of Directors. As a non-profit, the Board of Directors is positioned to continue driving the Rx-360® mission of pharmaceutical supply chain security, material quality, and patient safety. This announcement follows the organization’s successful growth in 2023.

PHILADELPHIA, Jan. 9, 2023 — Rx-360® is pleased to announce its 2023 Board of Directors. As a non-profit, the Board of Directors is positioned to continue driving the Rx-360® mission of pharmaceutical supply chain security, […]

Kate Silva is the Head of Quality Management Systems and Audits for MilliporeSigma. In this role, she is responsible for overseeing the global life science framework for compliance with quality, regulatory, and industry standards. Kate […]

Bill Campagna is the Senior Director of Quality for Procurement and Operations for Eli Lilly and Company; and he’s passionate about serving on Rx-360’s Board of Directors. “I’m proud to be part of Rx-360’s Board […]